REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 138 filers reported holding REVOLUTION MEDICINES INC in Q2 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $9,646,986 | – | 360,635 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nextech Invest Ltd. | 4,839,529 | $129,457,401 | 44.00% |
| Column Group LLC | 2,577,220 | $68,940,635 | 26.76% |
| Boxer Capital, LLC | 4,684,264 | $125,304 | 5.81% |
| EcoR1 Capital, LLC | 7,198,700 | $192,565,225 | 4.72% |
| BVF INC/IL | 6,255,588 | $167,336,979 | 4.66% |
| Casdin Capital, LLC | 1,810,000 | $48,417,500 | 4.23% |
| DAFNA Capital Management LLC | 512,285 | $13,703,624 | 3.75% |
| Artal Group S.A. | 2,401,617 | $64,243 | 1.99% |
| Bellevue Group AG | 4,746,000 | $126,955,500 | 1.81% |
| BioImpact Capital LLC | 273,408 | $7,313,664 | 1.47% |